March 21, 2022 12:30 PM
Newmark announces it has hired Jonathan Fanuzzi, a leading office leasing specialist, as an Executive Managing Director in the firm’s New York City office. Fanuzzi got his start in the industry at Newmark in 1999 and is a 23-year veteran known for providing agency leasing and tenant representation services for a wide range of asset classes and industries. He joins Newmark as one of the senior members of President of New York Tri-State Region David Falk’s team.
“It is great to have Jonathan back at Newmark as he has a long working history with many of our professionals, which will make for a seamless reintegration,” said Falk. “His strong work ethic and capabilities have commanded respect within the industry, and his presence will allow us to expand our business, foster cross-collaboration and deepen our bench of professional talent.”
Throughout his 23-year career, Fanuzzi has completed more than 18 million square feet of transactions across the United States for various clients. Owners and investors routinely seek him out to lead the leasing campaigns for some of New York City’s most prominent buildings, including the Empire State Building, 375 Park Avenue, 452 Fifth Avenue, 230 Park Avenue, 1166 Avenue of the Americas and 101 Avenue of the Americas.
As a tenant representative, Fanuzzi has worked with clients across a broad spectrum of industries, including law firms, boutique financial services companies, insurance firms, technology and life sciences groups. Notable clients include Syneos Health/INC Research, Parexel, First Light Fiber, Xtellus Capital, World Gold Council and L3 Technologies.
“Newmark continues to invest in its platform by acquiring the top talent in the industry to service the needs of our clients,” said Newmark CEO Barry Gosin. “Jonathan’s extensive experience, transactional creativity, and leadership skills allow him to craft innovative solutions for our clients in this evolving marketplace.”
Fanuzzi’s expertise in developing and executing innovative leasing strategies, coupled with his strong negotiation skills and deeply rooted relationships in the brokerage community, have cemented his reputation as one of the most respected leasing executives in New York City.
“These past two years have taught us to embrace agility to adapt to the needs of our clients as they reimagine the workplace in a post-pandemic world,” said Fanuzzi. “I’m looking forward to joining the Newmark platform and partnering with David Falk, Peter Shimkin and the talented group of professionals at the firm to provide our clients with a powerful suite of resources as they navigate the current landscape.
Fanuzzi returns to Newmark after a decade at JLL, where he was consistently ranked among the firm’s top national producers. While at JLL, his team was involved in some of the most creative projects in NYC, including HSBC’s 580,000-square-foot renewal at 452 Fifth Avenue, NY Genome Center’s 175,000-square-foot lease at 101 Avenue of the Americas, Syneos Health’s 87,000-square-foot relocation at 200 Vesey Street and over 240,000 square feet of leasing at 1166 Avenue of the Americas during the depths of the pandemic.
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. Newmark generated revenues in excess of $2.9 billion for the year ending December 31, 2021. Newmark’s company-owned offices, together with its business partners, operate from approximately 160 offices with over 6,200 professionals around the world. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.